News

CSCI Welcomes Dr Richard Tyser as Group Leader

19 April 2022

Dr Richard Tyser will join Cambridge Stem Cell Institute as a Principal Investigator this summer, bringing his expertise on the emergence of form and function during early heart development. Dr Tyser is coming from his post at the University of Oxford in the Department of Physiology, Anatomy and Genetics, where in 2018 he...

New research details communication between nerves and bone

10 March 2022

A new study was published today (10 March) in Cell Stem Cell , answering a question that’s been sitting unanswered for over thirty years. The research, led by Professor Simón Méndez-Ferrer’s Lab at Wellcome-MRC Cambridge Stem Cell Institute (CSCI), finally identified Interleukin-6 as a driver of an important switch that...

Megakaryocytes produced from human pluripotent stem cells

Mapping the way to improved transfusion products

7 March 2022

Research finds identifiers that can speed the process of in-vitro platelet production A new paper from the Wellcome-MRC Cambridge Stem Cell Institute (CSCI) and the UK Regenerative Medicine Platform has identified previously unknown markers of cells called megakaryocyte progenitors. This discovery will lead to better...

Research Provides New Explanation for Cell Organisation in Early Embryo Development

23 February 2022

New research from the Wellcome-MRC Cambridge Stem Cell Institute (CSCI) and the Department of Physiology, Development, and Neuroscience at the University of Cambridge (PDN) explores the self-organisation of tissues in early embryos, offering an explanation for how cells sort themselves as they develop. The paper, published...

Welcoming Dr Konstantinos Tzelepis to our Team of Principal Investigators

22 February 2022

Dr Konstantinos Tzelepis will join Cambridge Stem Cell Institute as a Principal Investigator, with research focusing on RNA modifications in stem cell homeostasis. Dr Tzelepis will be moving from The Milner Therapeutics Institute , where he also served as a PI. Prior to his appointment at Milner, he was a Wellcome...

Potential Therapeutic Target Found for Rare Blood Disorder

3 February 2022

Researchers have identified a new therapeutic target that could be critical in developing improved treatments for thrombocythaemia A new study from the Wellcome-MRC Cambridge Stem Cell Institute (CSCI), the Wellcome Sanger Institute, Department of Haematology at the University of Cambridge and Cambridge Institute for...

Live cells discovered in human breast milk could aid breast cancer research

27 January 2022

A new study from the Wellcome-MRC Cambridge Stem Cell Institute (CSCI) and the Department of Pharmacology at the University of Cambridge explores the cellular changes that occur in human mammary tissue in lactating and non-lactating women, offering insight into the relationship between pregnancy, lactation, and breast cancer.

Study finds that cancer-causing events can arise decades before symptoms occur

21 January 2022

Genetic mutations causing a type of adult blood cancer occur in childhood or even in the womb, new research has shown. A new study from the Wellcome Sanger Institute and the University of Cambridge has traced these mutations to childhood, showing that they proliferate in the body over decades before cancer symptoms later...

Robin Franklin accepts King Faisal Prize

Professor Robin Franklin receives King Faisal Prize in Medicine

13 January 2022

Over the winter holidays, Professor Robin Franklin of Cambridge Stem Cell Institute (CSCI) travelled to Saudi capital Riyadh to accept the King Faisal Prize for Medicine for his work in r egenerative medicine for neurological conditions .

CSCI Welcomes New Director

6 December 2021

Last week it was announced that Professor Bertie Göttgens has been appointed as Director of the Wellcome-MRC Cambridge Stem Cell Institute (CSCI), to begin in January 2022.